Statement of Changes in Beneficial Ownership (4)

FORM 4

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL

OMB Number:

3235-0287

Estimated average burden
hours per response...

0.5

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person * Overbaugh Jason G.	2. Issuer Name and Ticker or Trading Symbol SECURITY NATIONAL FINANCIAL CORP [ SNFCA ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) __X__ Director                    _____ 10% Owner __X__ Officer (give title below)    _____ Other (specify below) VP & Nat Mrk Dir of Life Ins
(Last)          (First)          (Middle) 13471 SOUTH TUSCALEE WAY	3. Date of Earliest Transaction (MM/DD/YYYY) 12/6/2019
(Street) DRAPER, UT 84020 (City)        (State)        (Zip)	4. If Amendment, Date Original Filed (MM/DD/YYYY)	6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right to buy)	$3.56 (1)	12/6/2013		A		13401 (1)		3/6/2014	12/6/2023	Class A Common Stock	13401 (1)	$3.56 (1)	13401 (1)	D
Employee Stock Option (right to buy)	$3.34 (2)	7/2/2014		A		12763 (2)		10/2/2014	7/2/2024	Class A Common Stock	12763 (2)	$3.34 (2)	12763 (2)	D
Employee Stock Option (right to buy)	$3.89 (3)	12/5/2014		A		25527 (3)		3/5/2015	12/5/2024	Class A Common Stock	25527 (3)	$3.89 (3)	25527 (3)	D
Employee Stock Option (right to buy)	$5.47 (4)	12/4/2015		A		24311 (4)		3/4/2016	12/4/2025	Class A Common Stock	24311 (4)	$5.47 (4)	24311 (4)	D
Employee Stock Option (right to buy)	$6.03 (5)	12/2/2016		A		23153 (5)		3/2/2017	12/2/2026	Class A Common Stock	23153 (5)	$6.03 (5)	23153 (5)	D
Employee Stock Option (right to buy)	$4.56 (6)	12/1/2017		A		22050 (6)		3/1/2018	12/1/2027	Class C Common Stock	22050 (6)	$4.56 (6)	22050 (6)	D
Employee Stock Option (right to buy)	$5.24 (7)	11/30/2018		A		26250 (7)		2/28/2019	11/30/2028	Class C Common Stock	26250 (7)	$5.24 (7)	26250 (7)	D
Employee Stock Option (right to buy)	$5.46 (8)	12/6/2019		A		30000 (8)		3/6/2020 (8)	12/6/2029	Class C Common Stock	30000 (8)	$5.46 (8)	30000 (8)	D

Explanation of Responses:
(1)	This option was granted on December 6, 2013 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $4.85 per share, but adjusted pursuant to the anti-dilution provisions of the 2003 Stock Option Plan to reflect 5% stock dividends paid on February 7, 2014, February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019.
(2)	This option was granted on July 2, 2014 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $4.29 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019.
(3)	This option was granted on December 5, 2014 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019.
(4)	This option was granted on December 4, 2015 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $6.72 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019.
(5)	This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, and February 1, 2019.
(6)	This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019.
(7)	This option was granted on November 30, 2018 as an option to purchase either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019.
(8)	This option was granted on December 6, 2019 as an option to purchase either 30,000 shares of Class A Common Stock at an exercise price of $5.46 per share or 30,000 shares of Class C Common Stock at an exercise price of $5.46 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 30,000 shares of Class C Common Stock at an exercise price of $5.46 per share. This option vests in four equal quarterly installments of Class C Common Stock, beginning on March 6, 2020, until such shares are fully vested.

Reporting Owners
Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Overbaugh Jason G. 13471 SOUTH TUSCALEE WAY DRAPER, UT 84020	X		VP & Nat Mrk Dir of Life Ins

Signatures
/s/Jason G. Overbaugh		12/18/2019
**Signature of Reporting Person		Date